AzTrials
AzTrials

Primary DysmenorrheaNCT06728306

Virtual Reality-Based Relaxation and Exergaming vs. Traditional Relaxation for Primer Dysmenorrhea

A study testing Immersive Virtual Reality-Based Relaxation, Non-immersive VR-Based Exergaming and Jacobson's Relaxation in people with Primary Dysmenorrhea, run by Trakya University at 2 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to investigate the acute effects of virtual reality-based relaxation (immersive VR relaxation) and exergaming (non-immersive VR) compared to traditional Jacobson's relaxation on symptoms of primary dysmenorrhea (PD) in women aged 18-30 years with regular menstrual cycles. Read more about this study

Who is it for?
Ages 18 to 30 years, women only
Conditions the study is for
Primary Dysmenorrhea
What is being tested?
Immersive Virtual Reality-Based Relaxation, Non-immersive VR-Based Exergaming and Jacobson's Relaxation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
43 participants
Where
2 sitesTurkey (Türkiye)
Study dates
12 May 2023to 5 Feb 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • women aged 18-30 with no pregnancy history.
  • a regular menstrual cycle (28 ± 7 days) over the past 6 months
  • menstrual pain with a Visual Analog Scale score >4 during this period

Who cannot join

  • regular medication use or medical treatment during the study (e.g., oral contraceptives, antidepressants).
  • recent musculoskeletal trauma or surgery.
  • intrauterine device use or pathological conditions/ultrasound findings of secondary dysmenorrhea
  • consumption of painkillers, alcohol, recreational drugs, or similar substances within the last 48 hours.

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Trakya University

    Edirne, İskender, 22100

  • Trakya University

    Edirne, 22100

Other trials in Turkey (Türkiye)

About this study

Official title: Acute Impact of Virtual Reality-Based Relaxation and Exergaming Compared to Traditional Relaxation on Primary Dysmenorrhea Symptoms: A Randomised Controlled Trial

The goal of this clinical trial is to investigate the acute effects of virtual reality-based relaxation (immersive VR relaxation) and exergaming (non-immersive VR) compared to traditional Jacobson's relaxation on symptoms of primary dysmenorrhea (PD) in women aged 18-30 years with regular menstrual cycles. The main questions it aims to answer are:

Does immersive VR relaxation reduce abdomino-pelvic pain and menstrual symptom severity more effectively than Jacobson's relaxation? Does non-immersive VR exergaming provide better pain relief and symptom management compared to traditional relaxation methods?

Read more

Hypotheses:

Immersive VR relaxation will result in significantly greater reductions in abdomino-pelvic pain and menstrual symptom severity compared to traditional relaxation.

Non-immersive VR exergaming will also provide better outcomes in pain and symptom management compared to traditional relaxation.

Researchers will compare immersive VR relaxation, non-immersive VR exergaming, and Jacobson's relaxation (control group) to determine the relative effectiveness of each intervention.

Participants will:

Engage in a 20-minute session of one of the assigned interventions. Complete questionnaires on abdomino-pelvic pain, menstrual symptoms, and perceived effectiveness.

Participate in follow-up assessments for sleep quality during menstruation. This study aims to explore innovative, technology-driven approaches for managing menstrual symptoms and their effectiveness relative to traditional methods.

Read the detailed description

This study seeks to address this gap by investigating whether these innovative approaches can provide superior symptom relief. By evaluating pain intensity, symptom severity, and perceived effectiveness, this research will provide valuable insights into the feasibility and advantages of integrating technology into dysmenorrhea management.

Being tested
Immersive Virtual Reality-Based Relaxation, Non-immersive VR-Based Exergaming, Jacobson's Relaxation
Keywords
Exercise Therapy, Pain Management, Primary Dysmenorrhea, Progressive Muscle Relaxation, Virtual Reality
Medical subject headings
Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Immersive Virtual Reality-Based RelaxationBehavioural

    Participants experienced a 20-minute immersive relaxation session using the virtual reality headset and the "Nature Treks" application, while seated comfortably. Participants were instructed to select the natural environment they found most relaxing from options such as "Blue Ocean," "Orange Sunset," "Violet Down," "White Winter," and "Green Meadows," and spent 20 minutes immersed in their chosen virtual environment.

  • Non-immersive VR-Based ExergamingBehavioural

    Participants engaged in a 20-minute calisthenic exercise session guided by the Kinect Adventures game on the Xbox Kinect 360 system. The exercise session consisted of playing two rounds each of the game segments "20,000 Leaks", "Reflex Ridge", and "River Rush", each lasting approximately 3 minutes

  • Jacobson's RelaxationBehavioural

    Participants underwent 20 minutes of progressive relaxation training as developed by Dr. Jacobson. The training involves a series of deep diaphragmatic breaths followed by the systematic tensing and relaxing of 16 major muscle groups throughout the body. Participants were guided through the exercise by an approximately 20-minute audio recording prepared by a psychologist and available online

Study groups in NCT06728306
Study groupRoleWhat they receive
Immersive Virtual Reality Based RelaxationExperimentalNot described
Receives: Behavioral: Immersive Virtual Reality-Based Relaxation
Non-Immersive Virtual Reality Based ExergamingExperimentalNot described
Receives: Behavioral: Non-immersive VR-Based Exergaming
Traditional Jacobson's RelaxationActive comparatorNot described
Receives: Behavioral: Jacobson's Relaxation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Abdomino-Pelvic Pain İntensity (APPI)

    Visuel Analogue Scale was used to measure abdomino-pelvic pain intensity. A 10 cm line was labeled with "0 cm" indicating no pain and "10 cm" representing unbearable pain at each end. Participants were asked to indicate their pain level by either drawing a line, placing a dot, or marking a point along the scale. Pain assessments were made for the most painful menstrual day and abdomino-pelvic pain on the intervention day.

    Measured: Immediately before and immediately after the 20-minute intervention session

  2. Menstruation-Related Symptoms

    The Daily Symptom Rating Scale (DSRS), a 17-item self-report tool, was used to assess the intensity of various menstrual symptoms, including pain, mood swings, and physical discomfort. Each symptom was rated on a scale from 0 (no symptoms) to 5 (severe), with higher scores indicating greater symptom severity. The Turkish version of the scale has been validated and shown to be reliable .

    Measured: Immediately before and immediately after the 20-minute intervention session

Secondary outcomes (1)
  1. Sleep Quality

    Richard Campbell Sleep Questionairre was used to assess sleep quality on the night following the intervention and during a non-intervention menstruation day. The six-item self-report questionnaire, validated in Turkish, evaluates aspects such as sleep depth, latency, frequency of awakenings, and overall quality, with higher scores indicating better sleep quality.

    Measured: The morning following the intervention and the morning of the most painful day during the subsequent menstrual cycle.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Dec 2024
  2. Study start12 May 2023
  3. Primary completion4 Feb 2024
  4. Study completion5 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
43 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06728306
Sponsor's protocol ID
TU-FTR-MŞY-002
Other IDs
1919B012219298
Status last verified
Dec 2024
First submitted
5 Dec 2024
Last updated
11 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Immersive Virtual Reality-Based Relaxation, Non-immersive VR-Based Exergaming and Jacobson's Relaxation in people with Primary Dysmenorrhea, run by Trakya University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Abdomino-Pelvic Pain İntensity (APPI) (time frame: Immediately before and immediately after the 20-minute intervention session). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2024; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in